Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cts (CTS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cts (CTS) over the last 16 years, with Q3 2025 value amounting to $5.4 million.

  • Cts' Gains from Investment Securities rose 3150.28% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 195.37%. This contributed to the annual value of $16.6 million for FY2024, which is 1796.89% down from last year.
  • Per Cts' latest filing, its Gains from Investment Securities stood at $5.4 million for Q3 2025, which was up 3150.28% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, Cts' Gains from Investment Securities ranged from a high of $7.5 million in Q4 2022 and a low of $2.5 million during Q1 2022
  • In the last 5 years, Cts' Gains from Investment Securities had a median value of $4.3 million in 2024 and averaged $4.5 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first skyrocketed by 8444.56% in 2021, then plummeted by 3167.4% in 2023.
  • Cts' Gains from Investment Securities (Quarter) stood at $6.6 million in 2021, then increased by 12.53% to $7.5 million in 2022, then crashed by 31.67% to $5.1 million in 2023, then fell by 12.73% to $4.5 million in 2024, then increased by 20.38% to $5.4 million in 2025.
  • Its Gains from Investment Securities stands at $5.4 million for Q3 2025, versus $4.2 million for Q2 2025 and $2.9 million for Q1 2025.